221 results
Page 2 of 12
8-K
EX-99.1
rdz 63c4nmma67
8 Dec 22
GeoVax Appoints Jayne Morgan, M.D., to its Board of Directors
3:53pm
8-K
EX-99.2
4lrfjokwg
14 Nov 22
GeoVax Reports 2022 Third Quarter
6:09am
8-K
EX-99.1
j0rcme6y75zl4vu6p
14 Nov 22
GeoVax Reports 2022 Third Quarter
6:09am
8-K
EX-99.1
mxu4 6rcfvkjv
4 Aug 22
GeoVax Reports 2022 Second Quarter Financial Results
4:06pm
8-K
EX-99.2
7g8mwpr48cqwod
4 Aug 22
GeoVax Reports 2022 Second Quarter Financial Results
4:06pm
424B3
ntuothtd po496gk
27 Jun 22
Prospectus supplement
9:13am
8-K
EX-10.4
umg6lnt9ov6o9
27 May 22
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
4:48pm
8-K
EX-10.5
js9rtdx6ati chfssu12
27 May 22
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
4:48pm
8-K
EX-10.1
1iipw6ng3 bf
27 May 22
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
4:48pm
424B5
56kk7bwu rz06
27 May 22
Prospectus supplement for primary offering
8:49am
8-K
EX-99.1
bple dyd74y5
2 May 22
GeoVax Reports 2022 First Quarter Financial Results
7:30am
8-K
EX-99.1
ulz0lhsh fm6r
10 Mar 22
GeoVax Reports 2021 Year-End Financial Results
5:02pm
POS AM
3xd0e8 f2k46j
9 Mar 22
Prospectus update (post-effective amendment)
8:42pm
POS AM
y469nl3o
9 Mar 22
Prospectus update (post-effective amendment)
8:40pm